Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00151281
What this trial is testing

Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Weill Medical College of Cornell University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Not applicableWithdrawnNCT01582685
What this trial is testing

Exercise in Breast Cancer Survivors

Who this might be right for
Breast CancerObesity
University of Mississippi Medical Center
Not applicableStudy completedNCT01998685
What this trial is testing

Prothrombotic Factors and Anaesthesia in Prostate Cancer

Who this might be right for
Prostatic CancerSurgery
Regina Elena Cancer Institute 200
Not applicableEnded earlyNCT02423785
What this trial is testing

Ocular Blood Flow in Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Medical University of Vienna 11
Early research (Phase 1)Ended earlyNCT02666547
What this trial is testing

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Who this might be right for
Pathological Angiogenesis
University of Lausanne Hospitals 42
Testing effectiveness (Phase 2)Study completedNCT00733304
What this trial is testing

An Extension to Study MD7108240

Who this might be right for
Macular Degeneration
GlaxoSmithKline 42
Testing effectiveness (Phase 2)WithdrawnNCT01633255
What this trial is testing

[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment

Who this might be right for
Kidney Neoplasms
National Cancer Institute (NCI)
Not applicableUnknownNCT03732235
What this trial is testing

TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer

Who this might be right for
Liver Metastasis Colon Cancer
Giammaria Fiorentini 50
Large-scale testing (Phase 3)Study completedNCT00532155
What this trial is testing

Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
CarcinomaNon Small Cell Lung
Sanofi 913
Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Not applicableUnknownNCT02293031
What this trial is testing

Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery

Who this might be right for
Maxillofacial Bone DefectsAlveolar Bone AtrophyJaw Fractures+3 more
NextGen Company Limited 12
Testing effectiveness (Phase 2)Ended earlyNCT00307723
What this trial is testing

Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Massachusetts General Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT06728852
What this trial is testing

Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)Recurrent or Metastatic Lung CancerThird-line and Beyond Therapy+1 more
Li-kun Chen 32
Not applicableUnknownNCT04731909
What this trial is testing

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageLung CancerSmall Cell Lung Cancer
Third Military Medical University 80
Testing effectiveness (Phase 2)Ended earlyNCT02808247
What this trial is testing

Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
European Organisation for Research and Treatment of Cancer - EORTC 80
Testing effectiveness (Phase 2)WithdrawnNCT01225510
What this trial is testing

A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Pfizer
Very early researchUnknownNCT02072720
What this trial is testing

Angiogenic Factor Expression During Fractionated Irradiation

Who this might be right for
Primary Esophageal Carcinoma
Amsterdam UMC, location VUmc 40
Early research (Phase 1)Study completedNCT00807859
What this trial is testing

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsBreast Tumors+7 more
Amgen 65
Large-scale testing (Phase 3)Study completedNCT00866697
What this trial is testing

Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer
Novartis Pharmaceuticals 940
Next Page